For many people with diabetes, low blood sugar means a glucose reading below 70 mg/dL. It can cause shaking, sweating, hunger, fast heartbeat, confusion, weakness, or fainting. Severe lows can be dangerous and may require help from another person, glucagon, or emergency care. Personal thresholds and treatment plans should come from a clinician.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does low blood sugar mean when you have diabetes?
Low blood sugar, also called low blood glucose or hypoglycemia, means glucose has fallen below the range that is safe for your body. For many people with diabetes mellitus, that action point is 70 mg/dL, but your diabetes care team may set a different number based on your medicines, age, pregnancy status, other health conditions, and history of lows 1.
Why glucose can fall below a safe range
Glucose is a main fuel for your brain and muscles. In diabetes, lows often happen when glucose-lowering treatment, food intake, activity, alcohol, illness, or kidney function are out of balance. Low blood glucose is especially common in type 1 diabetes and in type 2 diabetes when insulin or insulin-releasing medicines are used 1.
Why your personal low may differ from someone else’s
A person who often runs high may feel symptoms at a higher glucose level. A person with repeated lows may feel few warning signs even when glucose is already unsafe. This is one reason we encourage patients to know their personal plan, not just a single number from a chart. For broader context, see our normal blood sugar levels chart.
Quick facts: low blood sugar levels in diabetes
Hypoglycemia in diabetes is often discussed in 3 levels. The most useful way to think about it is: take action early, treat clinically significant lows seriously, and get help fast when thinking, swallowing, or consciousness is affected.
| Term | Glucose level or definition | What it means |
|---|---|---|
| Level 1 hypoglycemia | Below 70 mg/dL and at or above 54 mg/dL | An alert value. It is low enough that many people need to act and follow their diabetes plan. |
| Level 2 hypoglycemia | Below 54 mg/dL | Clinically significant low blood glucose. It can impair thinking and raises safety risk. |
| Level 3 hypoglycemia | Severe hypoglycemia requiring help from another person | Defined by altered mental or physical function, not by one glucose number. |
| Emergency situation | Seizure, loss of consciousness, inability to swallow safely, or severe confusion | Call emergency services and use glucagon if prescribed and available. |
The American Diabetes Association uses these levels to help clinicians track safety and treatment risk. Level 3, or severe hypoglycemia, is important because the person may not be able to self-treat 2.
What happens when a person with diabetes has low blood sugar?
When glucose drops, the body first releases stress hormones to warn you and push glucose back up. If glucose keeps falling, the brain may not get enough fuel, which can affect speech, judgment, movement, and consciousness 1.
Early warning symptoms
- Shaking or trembling
- Sweating or chills
- Sudden hunger
- Fast heartbeat
- Anxiety, irritability, or feeling “off”
- Dizziness, weakness, or headache
These symptoms can come on quickly. They are the body’s warning system, but symptoms alone are not always reliable, especially in people with repeated lows or long-standing diabetes 1.
Brain-related symptoms such as confusion or trouble speaking
As glucose falls further, a person may act confused, have trouble speaking, seem clumsy, have blurred vision, or become very sleepy. These brain-related symptoms are more concerning because the person may not be able to treat the low safely.
Why severe hypoglycemia can lead to seizures, coma, or death
Severe hypoglycemia can lead to seizure, coma, injury, and rarely death. Official diabetes guidance treats severe episodes as a major safety event, even when the exact glucose number is unknown 2.
What are the most common signs of low blood sugar?
The most common signs are shaking, sweating, hunger, fast heartbeat, and confusion. Five early signs can be enough to act, especially if you use insulin or a medicine that increases insulin release.
Five common signs patients notice first
- Shaky hands or body tremors
- Sweating that feels sudden or unusual
- Strong hunger
- A racing heartbeat
- Feeling confused, weak, anxious, or irritable
The NIDDK lists shakiness, sweating, hunger, fast heartbeat, irritability, dizziness, confusion, weakness, and fainting among common symptoms of low blood glucose 1.
Symptoms that can happen during sleep
Nocturnal hypoglycemia means low blood sugar during sleep. It may cause nightmares, sweating, restless sleep, morning headache, or waking up feeling tired. Some people do not wake up during a low, which is why a continuous glucose monitor can be useful for people at risk 1, 2.
What hypoglycemia unawareness means
Hypoglycemia unawareness means a person has fewer warning symptoms before glucose becomes dangerously low. It can happen after repeated lows and should prompt a clinical review of targets, medications, monitoring, and safety planning 2.
What blood sugar level is dangerously low for someone with diabetes?
A glucose value below 54 mg/dL is usually considered clinically significant and more dangerous than an alert-level low. Any low with seizure, fainting, severe confusion, or inability to swallow safely is an emergency, even if you do not know the number.
How 70 mg/dL, 54 mg/dL, and severe hypoglycemia differ
Below 70 mg/dL is commonly used as the point to take action. Below 54 mg/dL is a deeper low linked to higher safety risk. Severe hypoglycemia means another person’s help is needed because the person’s mental or physical function is impaired 2.
Why symptoms and risk can vary by person
Risk depends on the person’s medications, prior severe lows, kidney disease, heart disease, age, alcohol use, food intake, exercise, pregnancy, and ability to sense symptoms. People with a history of severe lows or lows without warning need a plan reviewed by their diabetes care team.
Why finger-stick meters and CGMs can both have limits
Blood glucose meters and continuous glucose monitors are both useful, but neither is perfect. Finger-stick meters can be affected by technique and strip issues, while CGMs measure glucose in interstitial fluid and can lag behind blood glucose when levels are changing fast 3.
A1C shows average glucose over roughly 2 to 3 months, but it does not show real-time lows, glucose swings, or time below range. That is why blood glucose monitoring or CGM matters for people prone to hypoglycemia 2.
What causes low blood sugar in diabetes?
Low blood sugar usually happens when diabetes medicine, food, activity, alcohol, illness, or organ function are out of balance. Insulin is a common cause, and insulin-releasing medicines can also raise the risk.
Insulin and medicines that increase insulin release
Insulin lowers glucose directly. Sulfonylureas and meglitinides make the pancreas release insulin, so they can cause low blood sugar, especially if meals are delayed or kidney function changes 1.
Skipping meals, delayed meals, or too few carbohydrates
If a person takes glucose-lowering medicine but eats less carbohydrate than expected, glucose may fall. This can happen with skipped meals, nausea, fasting, diet changes, or food insecurity.
Exercise and activity changes
Physical activity can lower glucose during or after exercise. In a randomized trial of adults with type 2 diabetes and possible sarcopenia, 12 weeks of progressive sandbag exercise improved glycemic control and muscle strength, but people using glucose-lowering medicines still need a plan for preventing lows around activity 4.
Alcohol, illness, and fasting
Alcohol can increase the risk of low blood sugar, especially without enough food. Illness, vomiting, reduced appetite, fasting, and changes in routine can also make glucose harder to predict 1.
Medication changes and kidney or heart disease risk factors
Medication dose changes, kidney disease, and serious illness can change how the body handles diabetes medicines. Repeated lows should not be treated as “normal”; they are a reason to review the diabetes plan.
What should someone with diabetes eat or drink when blood sugar is low?
For mild low blood sugar when a person is awake and able to swallow safely, diabetes guidance commonly uses fast-acting carbohydrates. If the person is confused, unconscious, seizing, or cannot swallow safely, do not give food or drink by mouth.
Fast-acting carbohydrates and why they are used
Fast-acting carbohydrates are used because they can raise glucose faster than foods that digest slowly. Examples include glucose tablets, glucose gel, regular juice, regular soda, or hard candy, depending on the person’s diabetes plan 1.
If you are comparing options, our guides to glucose tablets for hypoglycemia and low blood sugar symptoms explain how people commonly prepare for lows.
Why high-fat foods may work more slowly
Foods high in fat, such as chocolate or full meals, can slow digestion. They may not raise glucose as quickly as fast-acting carbohydrate during an active low 1.
Why severe symptoms need help, not food or drink by mouth
When a person cannot swallow safely, food or drink can cause choking. Severe hypoglycemia may require another person’s help, glucagon if prescribed, and emergency services 1.
How can low blood sugar be prevented?
Prevention starts with matching medicines, meals, movement, alcohol, sleep, and sick-day plans. Monitoring with a meter or CGM helps show patterns so the care team can adjust the plan.
Monitoring with a blood glucose meter or CGM
The ADA notes that blood glucose monitoring and CGM can support diabetes self-management and are especially useful for safety in people taking insulin. CGM can show time below range and can alert people to lows, including overnight lows 2. Learn more in our guide to a continuous glucose monitoring system.
Medication review with a diabetes care team
If lows are happening often, the answer is not just to eat more sugar. A clinician may review the type, timing, and amount of diabetes medicine; kidney function; meal patterns; alcohol; exercise; and glucose targets.
Planning for meals, exercise, alcohol, sleep, and sick days
A written plan can cover what to carry, when to check glucose, how to handle activity, what to do during illness, when to use glucagon, and when to call for help. Diabetes group care and structured education can improve self-management outcomes in community settings, though the right format varies by person 5.
Why repeated lows should prompt a clinical review
Repeated lows can raise the risk of hypoglycemia unawareness. They can also signal that the current plan is too aggressive or no longer fits the person’s life, weight, kidney function, food intake, or activity pattern 2.
Which next step fits which person?
The right next step depends on how low the glucose is, what symptoms are present, and what medicines the person uses. This table is not a diagnosis, but it can help you decide what kind of help to seek.
| Situation | Sensible next step | Why it matters |
|---|---|---|
| Awake, able to swallow, glucose below personal low threshold | Follow your clinician’s low-blood-sugar plan using fast-acting carbohydrate. | Mild lows can often be self-treated when the person is alert and safe to swallow. |
| Confusion, seizure, fainting, or cannot swallow safely | Seek emergency help; use glucagon if prescribed and available. | Food or drink by mouth can be unsafe, and the person may not be able to self-treat. |
| Repeated lows or lows without warning symptoms | Schedule a diabetes medication and monitoring review. | The treatment plan may need changes to reduce safety risk. |
| Lows during sleep or fear of overnight lows | Ask about CGM alerts, bedtime patterns, alcohol, evening exercise, and medication timing. | Nocturnal hypoglycemia can be missed without monitoring. |
| Considering weight-loss medication while using insulin, sulfonylureas, or meglitinides | Get clinician review before starting GLP-1 or dual GIP/GLP-1 therapy. | Adding weight-loss treatment can change appetite, intake, and medication needs. |
3-min quiz
Considering weight-loss treatment with diabetes medicines on board?
Chia offers clinician-reviewed access to compounded semaglutide injection and compounded tirzepatide tablets or injection when clinically appropriate. GLP-1 treatment is not emergency treatment for low blood sugar. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved and are compounded in the US by state-licensed 503A pharmacies.
How does low blood sugar risk affect GLP-1 treatment at Chia?
GLP-1 medicines are not used to rescue low blood sugar. At Chia, the key safety question is whether weight-loss treatment could change food intake or interact with a person’s diabetes medicines, especially insulin or insulin-releasing drugs.
Why GLP-1 medicines are not emergency treatment for hypoglycemia
Semaglutide, sold as Ozempic, Wegovy, and Rybelsus in FDA-approved brand forms, is a GLP-1 receptor agonist. Tirzepatide, sold as Mounjaro and Zepbound in FDA-approved brand forms, is a dual GIP/GLP-1 receptor agonist. These medicines can support weight and glucose goals in selected patients, but they do not replace fast-acting carbohydrate, glucagon, or emergency care for an active low.
Why people using insulin or insulin-releasing medicines need clinician review
FDA labeling for semaglutide and tirzepatide warns that hypoglycemia risk can increase when these medicines are used with insulin or insulin secretagogues, such as sulfonylureas. That is why medication history matters before starting treatment 6, 7.
Semaglutide at Chia
Chia offers compounded semaglutide injection through a licensed provider evaluation, with microdosing plans available when clinically appropriate. Plans currently start at $249/mo; the product page has current details. Compounded formulations are separate from FDA-approved brand products and do not have FDA-evaluated outcomes data.
Tirzepatide at Chia
Chia offers compounded tirzepatide tablets and injection, with microdosing plans available when clinically appropriate. Plans currently start at $249/mo for tablets and $299/mo for injection; the product page has current details.
| Chia treatment | Forms Chia offers | Current starting price | Where low-blood-sugar review fits |
|---|---|---|---|
| Compounded semaglutide | Injection | From $249/mo | Provider reviews diabetes medicines, history of lows, contraindications, and goals before deciding if prescribing is appropriate. |
| Compounded tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | Provider reviews insulin or insulin-releasing medicines, eating patterns, GI history, and safety risks before prescribing. |
How Chia’s online evaluation fits into safe access
Treatment at Chia is 100% online: a short health questionnaire, then a licensed US provider reviews your history and prescribes only when clinically appropriate. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Dosing is provider-guided, and patients can message their care team through the portal between visits.
If you are researching online access, our guide to semaglutide injections online explains what to check for when a prescription medication is being evaluated through telehealth.
When should low blood sugar lead to urgent medical help?
Get urgent help when low blood sugar affects consciousness, swallowing, speech, behavior, or seizure risk. Severe hypoglycemia is a safety event, even if the number is not known.
Loss of consciousness, seizure, or inability to swallow safely
Call emergency services if a person is unconscious, having a seizure, unable to swallow safely, or not improving as expected. Use glucagon if it has been prescribed and a trained person is available to give it 1.
Repeated lows or lows without warning symptoms
Repeated lows, nighttime lows, or lows without warning symptoms should be reviewed with a clinician. The plan may need changes to medication, meal timing, glucose targets, CGM alerts, or activity planning.
Low blood sugar during pregnancy, illness, or medication changes
Pregnancy, illness, vomiting, fasting, and medication changes can all shift glucose needs. People in these situations should follow their diabetes care team’s instructions and seek urgent help for severe symptoms 1, 2.
3-min quiz
Start with a clinician-reviewed plan
If you have diabetes and are exploring weight-loss medication, Chia can review whether compounded semaglutide or compounded tirzepatide may fit your goals and safety profile. A prescription is never guaranteed and depends on a licensed provider’s evaluation. Chia does not treat acute hypoglycemia emergencies.
You may feel shaky, sweaty, hungry, anxious, weak, dizzy, or confused. If glucose keeps falling, you may have trouble speaking, walking, seeing clearly, or staying awake. Severe low blood sugar can cause seizure or loss of consciousness and needs urgent help.
Many people use below 70 mg/dL as the point to take action. Below 54 mg/dL is usually considered clinically significant and more dangerous. Any low with seizure, fainting, severe confusion, or inability to swallow safely is an emergency.
If the person is awake and can swallow safely, diabetes plans often use fast-acting carbohydrates such as glucose tablets, glucose gel, juice, regular soda, or hard candy. If the person is confused, unconscious, seizing, or unable to swallow safely, do not give food or drink by mouth; seek emergency help.
Five common signs are shakiness, sweating, sudden hunger, fast heartbeat, and confusion. Other symptoms can include anxiety, irritability, dizziness, weakness, headache, blurred vision, or fainting.
Type 2 diabetes itself does not always cause low blood sugar, but lows can happen in people with type 2 diabetes who use insulin or medicines that increase insulin release. Skipped meals, exercise changes, alcohol, illness, fasting, or kidney problems can add risk.
Yes. This is called nocturnal hypoglycemia. It may cause sweating, nightmares, restless sleep, morning headache, or tiredness. Some people do not wake up during a low, so people at risk should ask their care team whether CGM alerts or a different plan may help.
A CGM can help by showing glucose trends and giving low-glucose alerts, including during sleep. It does not replace a treatment plan, and readings can lag when glucose is changing quickly, but it can be a useful safety tool for people prone to lows.
GLP-1 and dual GIP/GLP-1 medicines have a higher low-blood-sugar concern when used with insulin or insulin-releasing medicines such as sulfonylureas. They are not emergency treatment for hypoglycemia. Compounded semaglutide and compounded tirzepatide are not FDA-approved, and eligibility requires clinician evaluation.
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases. Low Blood Glucose (Hypoglycemia). NIDDK, 2024.
- 2.American Diabetes Association Professional Practice Committee. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes. Diabetes Care, 2026.
- 3.Mathew TK, Zubair M, Tadi P. Blood Glucose Monitoring. StatPearls. National Library of Medicine, 2025.
- 4.Chien YH, Tsai CJ, Wang DC, et al. Effects of 12-Week Progressive Sandbag Exercise Training on Glycemic Control and Muscle Strength in Patients with Type 2 Diabetes Mellitus Combined with Possible Sarcopenia. International Journal of Environmental Research and Public Health, 2022.
- 5.Baig AA, Staab EM, Benitez A, et al. Impact of diabetes group visits on patient clinical and self-reported outcomes in community health centers. BMC Endocrine Disorders, 2022.
- 6.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. FDA, 2025.
- 7.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2025.
- 8.International Hypoglycaemia Study Group. The Need to Change Regulatory Evaluation of Hypoglycemia in Diabetes. Diabetes Care, 2020.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
